Norgam Medicaments Private Limited, a active private limited company, was established on 18 February 2021 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U85100GJ2021PTC120351. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹0.10 M.
Employing 44 professional, Its leadership includes Karmeshkumar Ravajibhai Lakhani (Director), Chaganbhai Trikambhai Lakhani (Director), Natvarlal Virjibhai Hirapara (Director). Past directors included Chaganbhai Trikambhai Lakhani, Natvarlal Virjibhai Hirapara, Pankajkumar Mansukhbhai Tavethiya. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at J-301,White Elegance,Third Floor, Naroda Dehgam Rd Hanspura, Tal: Ahmedabad City,, Ahmedabad, Gujarat, 382330.
U85100GJ2021PTC120351
120351
18 February 2021
₹3.00 Cr
₹0.10 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Norgam Medicaments Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Karmeshkumar Ravajibhai Lakhani | Director | 18 Feb 2021 | Current |
| Chaganbhai Trikambhai Lakhani | Director | 12 Jun 2021 | Current |
| Natvarlal Virjibhai Hirapara | Director | 12 Jun 2021 | Current |
| Pankajkumar Mansukhbhai Tavethiya | Director | 12 Jun 2021 | Current |
| Bharatkumar Ravajibhai Lakhani | Director | 18 Feb 2021 | Current |
| Ashokkumar Vitthalbhai Tavethia | Director | 21 Apr 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Dec 2022 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2022 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2022 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Norgam Medicaments Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 224.68% increase. The company also saw a substantial fall in profitability, with a 42.54% decrease in profit. The company's net worth observed a substantial decline by a decrease of 143.87%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Norgam Medicaments's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Norgam Medicaments has a workforce of 44 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Norgam Medicaments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Norgam Medicaments's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Norgam Medicaments Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Norgam Medicaments Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was recorded as a recent event.
Progress on Chaganbhai Trikambhai Lakhani was appointed as a Director was appointed as a Director on 12 Jun 2021 & has been associated with this company since 4 years 7 months . was documented.
Progress on Natvarlal Virjibhai Hirapara was appointed as a Director was appointed as a Director on 12 Jun 2021 & has been associated with this company since 4 years 7 months . was documented.
The activity Pankajkumar Mansukhbhai Tavethiya was appointed as a Director was appointed as a Director on 12 Jun 2021 & has been associated with this company since 4 years 7 months . was completed.
Progress on Ashokkumar Vitthalbhai Tavethia was appointed as a Director was appointed as a Director on 21 Apr 2021 & has been associated with this company since 4 years 9 months . was documented.
The CIN of Norgam Medicaments Private Limited is U85100GJ2021PTC120351.
Norgam Medicaments Private Limited is headquartered at J-301,White Elegance,Third Floor, Naroda Dehgam Rd Hanspura, Tal: Ahmedabad City,, Ahmedabad, Gujarat, 382330.
Norgam Medicaments Private Limited was incorporated on 18 February 2021.
The current directors of Norgam Medicaments Private Limited are
The primary industry of Norgam Medicaments Private Limited is Trade.
Norgam Medicaments Private Limited is unlisted.
The authorized capital of Norgam Medicaments Private Limited is ₹3.00 Cr, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX